FBLG Earnings Date: Oct 30, 2026 (Estimated) — FibroBiologics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology
Updated
When is FBLG's next earnings date?
FibroBiologics, Inc. Common Stock (FBLG) is expected to report Q3 2026 earnings on Friday, October 30, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.63.
How did FBLG do in its last earnings report?
In its most recent report on Jul 31, 2026 (Q2 2026), FibroBiologics, Inc. Common Stock posted EPS of -$0.66 versus the -$0.93 estimate, a beat of 29.0%. Revenue was $0. The stock's 1-day post-earnings move was +12.9%.
How much does FBLG stock move after earnings?
FBLG beat EPS estimates in 3 of its last 7 reported quarters. Over the last 7 reports the stock moved an average of 10.2% (up or down) in the day after earnings.
About FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage investigations are underway for CYTER915, aimed at restoring or enhancing thymus and/or spleen function; CYPS317, for psoriasis; and TCB190, designed to combat specific cancers. FibroBiologics was founded in 2021 and is situated in Houston, Texas.
🤖 AI Earnings Analysis
FBLG’s recent updates center on patent protection and preclinical data—not clinical efficacy; at $0.93 and a negative P/E of −0.16, it remains a highly speculative, loss-making biotech.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | Q2 2026 | -0.93 | -0.66 | +29.03% | $0 | ✅ Beat | +12.93% | +39.46% | +145.71% |
| 2026-04-30 | Q1 2026 | -1.33 | -1.33 | +0.00% | $0 | ➖ Inline | +10.61% | -6.06% | -15.15% |
| 2026-02-24 | Q4 2025 | -2.00 | -0.60 | +70.00% | $0 | ✅ Beat | -1.57% | +45.50% | -1.50% |
| 2025-10-31 | Q3 2025 | -0.11 | -0.13 | -18.18% | $0 | ❌ Miss | +0.33% | -10.40% | -33.08% |
| 2025-07-31 | Q2 2025 | -0.12 | -0.12 | +0.00% | $0 | ➖ Inline | +1.81% | -16.17% | -7.38% |
| 2025-03-31 | Q4 2024 | -0.07 | -0.09 | -28.57% | $0 | ❌ Miss | -4.44% | -3.33% | +24.44% |
| 2024-08-07 | Q2 2024 | -0.09 | 0.03 | +133.33% | $0 | ✅ Beat | -39.41% | -53.89% | -43.97% |
| 2024-05-14 | Q1 2024 | — | -0.27 | — | $0 | — | — | — | — |
Showing last 8 quarters.